Innovative clinical studies and long-term treatment consequences

is part of MoHAD: Mechanisms of Health, Ageing and Disease

Programme

is part of MoHAD: Mechanisms of Health, Ageing and Disease

Further improvement in the outcomes of cancer treatments requires innovative trial designs within a state-of-the-art clinical trial organization. In addition to improving treatments for major tumor subtypes through clinical trials, we aim to improve care for patients with rare cancers.

While optimizing treatment efficacy, we strive to prevent or reduce the adverse side effects of cancer treatments and improve the quality of life. Using our OncoLifeS cohort, we conduct innovative longitudinal (e-health) monitoring of early and long-term treatment consequences and side effects in survivors to enhance psychosocial well-being. Furthermore, we study how palliative care can be optimally implemented to improve quality of life.

The Innovative clinical studies and long-term treatment consequences program includes the following research areas:

Early clinical trials
Rare Cancers
OncoLifeS - A prospective oncology Cohort, which we aim to expand to Northern region of the Netherlands in collaboration with our regional partner hospitals
Treatment related side effects and quality of life
Cancer Survivorship
Palliative Care
Development of new care strategies (e.g. Shared decision making, Shared-care)